PAR-2 Antibodies

Santa Cruz Biotechnology features a diverse variety of PAR-2 monoclonal antibodies for research focused on understanding protease-activated receptor 2 (PAR-2) in various biological processes. PAR-2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).PAR-2 is a G protein-coupled receptor that plays a critical role in mediating inflammatory responses and pain signaling. When activated by proteolytic cleavage, PAR-2 initiates a cascade of intracellular signaling events that influence cell behavior and tissue homeostasis. Understanding PAR-2 function is essential for elucidating its involvement in various pathophysiological conditions, including chronic pain, inflammation, and cancer. Research has shown that PAR-2 expression levels vary significantly across different tissue types and disease states. PAR-2 signaling pathways have emerged as potential therapeutic targets for treating inflammatory disorders. Recent studies have highlighted PAR-2's role in neurogenic inflammation and its potential implications in developing new treatment strategies. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance their understanding of PAR-2's role in human health and disease.